BONNY MOORE, MD
Hematology & Oncology Physician · FREDERICKSBURG, VA
Individual Active NPI 1902048051
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,600 | 350,160 | $13,414,646 | $6,673,965 | $5,327,266 |
| 2023 | 1,523 | 289,788 | $10,669,504 | $5,217,914 | $4,159,059 |
| 2022 | 1,723 | 382,850 | $14,636,448 | $7,151,674 | $5,719,156 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 104,250 | $1 | $1 |
| J9271 | Injection, pembrolizumab, 1 mg | 18,000 | $56 | $45 |
| J9299 | Injection, nivolumab, 1 mg | 14,360 | $31 | $25 |
| J0897 | Injection, denosumab, 1 mg | 13,680 | $25 | $20 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 12,501 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 12,480 | $2 | $1 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 11,748 | $26 | $21 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 11,000 | $45 | $36 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 10,080 | $49 | $39 |
| Q5125 | Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | 9,600 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 8,400 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 7,972 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 0101249938 | VA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Virginia
- NPI 1801752647
- NPI 1700742541
- NPI 1194248435
- NPI 1114301561
- NPI 1861855454
- NPI 1386675999
- NPI 1851322499
- NPI 1588681233
See all Hematology & Oncology Physician providers in Virginia →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.